• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OSX

OSTEOPORE LIMITED - News & Media

15.4% ! 1.5¢
Market Cap $2.601M  !
Healthcare Medical Devices
Add to My Watchlist

Osteopore Limited is an Australia-based regenerative medicine company engaged in... Osteopore Limited is an Australia-based regenerative medicine company engaged in three-dimensional (3D)-printed biomimetic and bioresorbable implants. The Company seeks to commercialize products that stimulate natural bone healing across multiple segments. It creates patented scaffolds using 3D-printed biomimetic and bioresorbable materials to guide and nurture bone-forming cells. Through its proprietary manufacturing process, which uses a naturally dissolving polymer, its patented scaffolds enable bone tissue growth, significantly reducing the post-surgery complications commonly associated with permanent bone implants. The Company’s surgical specialty includes craniotomy, orbital floor reconstruction, socket preservation, cranioplasty patient-specific implants (PSI), craniosynostosis, guided bone regeneration, endoscopic transsphenoidal skull base surgery, burr hole restoration with the shunt drainage system, mandible PSI, and immediate implant loading, among others.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Articles & Videos

Osteopore winds up 3D printed bone implant study bankrolled by the Chilean Government

Osteopore Limited (ASX:OSX) has reported its conclusion of a research program funded by the Chilean government to create a 3D printed bone implant to aid regenerative healing.

22 Aug 2024 10:07 (AEST)

Osteopore plunges from 1000% price surge to suspension order

Osteopore goes from a 1000% price surge on Wednesday to a suspension order today after failing to submit its annual report

28 Mar 2024 12:27 (AEDT)

Osteopore stock spikes 900% on Singapore and Vietnam approvals

Osteopore's (ASX:OSX) share price was up 38% after the regenerative medicine company received approval for its orthopaedic products to be marketed across Singapore and Vietnam.

27 Mar 2024 11:43 (AEDT)

Osteopore (ASX:OSX) secures $10m commitment from CellHeal to launch into Chinese market

Osteopore (ASX:OSX) has signed a non-binding term sheet with CellHeal which is committing $10 million to push commercialisation in China.

25 Jul 2023 12:20 (AEST)

Osteopore (ASX:OSX) announces leadership changes with key appointments

Medical technology company Osteopore changes its leadership team adding Hon. Michael Keenan as Non-Executive Director and Dr Lim Jing to CEO.

18 Jul 2023 15:28 (AEST)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.5¢ 		Change
0.002(15.4%) 		Mkt cap ! $2.601M
Open High Low Value Volume
1.4¢ 1.5¢ 1.3¢ $21.93K 1.668M

Buyers (Bids)

No. Vol. Price($)
11 1344277 1.3¢
 

Sellers (Offers)

Price($) Vol. No.
1.5¢ 194010 1
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
OSX (ASX) Chart

Top Stories

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Welcome to this week’s HotCopperWire, our market watch podcast!Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through all the week’s biggest news headlines @ and what they mean for Aussie investors.In this Week ...
ASX Ltd notches upward on sale of company meant to fix CHESS 3 years ago ASX Ltd (ASX:ASX) has notched fractional gains in early Friday trades on the news it's ditched its shareholdings in...
Zip's stunning comeback: Is this the start of a $14 revival? Just when the market had written it off… Zip Co (ASX: ZIP) has come roaring back to life. The Buy Now, Pay Later company stunned investors last Wednesday with a 15% surge in its share price soon after upgrading its full-year earnings forecast to at least $160 million @ up from $153 million...
Clinuvel shares dip, even as CEO comes back from temp leave After Clinuvel's (ASX:CUV) CEO Dr. Philippe Wolgen took time off back in March to respond to an "acute medical condition," it wasn't...
Resolution's dual-listing to 'expedite growth' – and sets stage for NASDAQ foray Resolution Minerals (ASX:RML) is on the verge of listing on the OTCQB @ oft called the @Venture Market” over in the States @ as it looks to @expedite growth” and @unlock value” through the bold U.S. index expansion.Listen to the Ho...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.